Biopharmaceutical company DiscGenics has raised $50 million in a Series C funding round, according to an Aug. 25 news release.
The Latest
The FDA has approved the third drug for the treatment of neuromyelitis optica spectrum disorder, which affects the optic nerves and spinal cord, according to an Aug. 17 news release.
The Environmental Protection Agency on Aug. 24 gave emergency approval for the use of a new COVID-19 cleanser that claims to kill the virus on surfaces for up to seven days, The Washington Post reports.
Medtronic on Aug. 25 reported first quarter revenue decreased 13 percent year over year to $6.5 billion.
Here are two female neurosurgeons making the news in the past month:
Here are eight spine and neurosurgeons that made headlines last week:
Spine surgeon Daryll Dykes, MD, PhD, joined the orthopedic team at Auburn (N.Y.) Community Hospital, according to auburnpub.com.
Wooster, Ohio-based Bloomington Orthopedic Specialists has welcomed spine surgeon Marcus Newton, DO, to its team, This Week Community News reported Aug. 23.
Erik Bowman, MD, and Kathleen Kollitz, MD, are the newest hires at BoulderCentre for Orthopedics & Spine.
Former CommonSpirit Health CEO Kevin Lofton is joining Medtronic's board of directors, effective Sept. 15.